COMMUNIQUÉS West-GlobeNewswire

Shire plc : Director/PDMR Shareholding
22/08/2017
Director/PDMR Shareholding August 22, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Medtronic Reports First Quarter Financial Results
22/08/2017
Revenue of $7.390 Billion Grew 3% as Reported; 4% at Constant Currency GAAP Diluted EPS of $0.74; Q1 Non-GAAP Diluted EPS of $1.12 GAAP Operating Margin Improved 250bps; Non-GAAP Operating Margin Improved 50bps at [...]
AC IMMUNE DISCOVERS NEXT-GENERATION ANTIBODIES FOCUSED ON NEURODEGENERATIVE DISEASES
22/08/2017
Pipeline expansion with new antibodies against alpha-synuclein and TDP-43 Proprietary scientific approach rapidly delivers high-quality assets Execution of clear strategy around three pillars Alzheimer's disease Other [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
22/08/2017
FIT Biotech Oy Company release August 22, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Solon Eiendom ASA : Invitation to presentation of second quarter 2017 results
22/08/2017
Oslo, 22 August 2017 - Solon Eiendom ASA will publish its second quarter 2017 results on Tuesday 29 August at 06.30 am CET. The quarterly report and the presentation materials will be available on the company's web site [...]
Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September
22/08/2017
Press Release 22 August 2017 Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.
21/08/2017
COPENHAGEN, Denmark, August 21, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the closing of the transaction with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of [...]
Sanofi : Disclosure of trading in own shares
21/08/2017
Disclosure of trading in own shares This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Sanofi : Déclaration des transactions sur actions propres
21/08/2017
Déclaration des transactions sur actions propres This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]
Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead
21/08/2017
Clinical Trial Also Underway in U.S., Canada and Other Geographies DUBLIN - August 21, 2017 - Medtronic plc (NYSE: MDT) announced it has received CE ( Conformité Européene ) Mark for the Attain Stability(TM) Quad MRI [...]
CORRECTION - Ossur Hf : Transactions in relation to share buyback program
21/08/2017
This is a correction of the announcement from 16:00 21.08.2017 CEST, NO: 61/2017. Reason for the correction: Header incorrect, other information in the announcement is correct. Previous Header: Share buyback program [...]
PCI Biotech: Invitation to first half year 2017 presentation
21/08/2017
Oslo, 21 August 2017 - PCI Biotech invites to a presentation of the company's second quarter and first half year 2017 report on Tuesday 29 August 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday August 29, [...]
Ossur Hf : Share buyback program completed
21/08/2017
Announcement from Össur hf. No. 61/2017 Reykjavík, 21 August 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program was to [...]
Novo Nordisk A/S - Share repurchase programme
21/08/2017
Bagsværd, Denmark, 21 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Pages